These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25178102)

  • 1. Inhibition of human melanoma growth by a non-cardioselective β-blocker.
    Wrobel LJ; Le Gal FA
    J Invest Dermatol; 2015 Feb; 135(2):525-531. PubMed ID: 25178102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol induced G0/G1/S phase arrest and apoptosis in melanoma cells via AKT/MAPK pathway.
    Zhou C; Chen X; Zeng W; Peng C; Huang G; Li X; Ouyang Z; Luo Y; Xu X; Xu B; Wang W; He R; Zhang X; Zhang L; Liu J; Knepper TC; He Y; McLeod HL
    Oncotarget; 2016 Oct; 7(42):68314-68327. PubMed ID: 27582542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockers exert potent anti-tumor effects in cutaneous and uveal melanoma.
    Bustamante P; Miyamoto D; Goyeneche A; de Alba Graue PG; Jin E; Tsering T; Dias AB; Burnier MN; Burnier JV
    Cancer Med; 2019 Dec; 8(17):7265-7277. PubMed ID: 31588689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the effects of nonselective and cardioselective β-blockers on wound healing in Sprague Dawley rats.
    Raut SB; Nerlekar SR; Pawar S; Patil AN
    Indian J Pharmacol; 2012; 44(5):629-33. PubMed ID: 23112427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of pancreatic cancer cell proliferation by propranolol occurs through apoptosis induction: the study of beta-adrenoceptor antagonist's anticancer effect in pancreatic cancer cell.
    Zhang D; Ma Q; Shen S; Hu H
    Pancreas; 2009 Jan; 38(1):94-100. PubMed ID: 19106745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive effect of a non-selective (propranolol) and a cardioselective (metoprolol) beta-adrenoceptor blocking agent at rest and during exercise.
    Clausen N; Damsgaard T; Mellemgaard K
    Br J Clin Pharmacol; 1979 Apr; 7(4):379-83. PubMed ID: 375959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization.
    Dal Monte M; Casini G; Filippi L; Nicchia GP; Svelto M; Bagnoli P
    J Mol Med (Berl); 2013 Dec; 91(12):1407-19. PubMed ID: 23907236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of beta-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist: differential effects of propranolol, nadolol and metoprolol.
    Goldberg MR; Sciberras D; De Smet M; Lowry R; Tomasko L; Lee Y; Olah TV; Zhao J; Vyas KP; Halpin R; Kari PH; James I
    Br J Clin Pharmacol; 2001 Jul; 52(1):69-76. PubMed ID: 11453892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man.
    Thomas MS; Tattersfield AE
    Eur J Clin Pharmacol; 1986; 29(6):679-83. PubMed ID: 2872056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term application of metoprolol and propranolol in a rat model of smoking.
    Zhou Y; Xu M; Zhang Y; Guo Y; Zhang Y; He B
    Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):708-15. PubMed ID: 24837395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancer.
    Montoya A; Amaya CN; Belmont A; Diab N; Trevino R; Villanueva G; Rains S; Sanchez LA; Badri N; Otoukesh S; Khammanivong A; Liss D; Baca ST; Aguilera RJ; Dickerson EB; Torabi A; Dwivedi AK; Abbas A; Chambers K; Bryan BA; Nahleh Z
    Oncotarget; 2017 Jan; 8(4):6446-6460. PubMed ID: 28031536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
    Hansen O; Johansson BW
    J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men.
    Sklar J; Johnston GD; Overlie P; Gerber JG; Brammell HL; Gal J; Nies AS
    Circulation; 1982 May; 65(5):894-9. PubMed ID: 7074750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Training-induced bradycardia in rats on cardioselective and non-selective beta receptor blockade.
    Nylander E
    Acta Physiol Scand; 1985 Feb; 123(2):147-9. PubMed ID: 2858958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nebivolol on proliferation and apoptosis of human coronary artery smooth muscle and endothelial cells.
    Brehm BR; Wolf SC; Bertsch D; Klaussner M; Wesselborg S; Schüler S; Schulze-Osthoff K
    Cardiovasc Res; 2001 Feb; 49(2):430-9. PubMed ID: 11164853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphasic effects of propranolol on tumour growth in B16F10 melanoma-bearing mice.
    Maccari S; Buoncervello M; Rampin A; Spada M; Macchia D; Giordani L; Stati T; Bearzi C; Catalano L; Rizzi R; Gabriele L; Marano G
    Br J Pharmacol; 2017 Jan; 174(2):139-149. PubMed ID: 27792834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Adrenoceptor blockers and pulmonary function in the general population: the Rotterdam Study.
    Loth DW; Brusselle GG; Lahousse L; Hofman A; Leufkens HG; Stricker BH
    Br J Clin Pharmacol; 2014 Jan; 77(1):190-200. PubMed ID: 23772842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blockers reduce the release and synthesis of endothelin-1 in human endothelial cells.
    Garlichs CD; Zhang H; Mügge A; Daniel WG
    Eur J Clin Invest; 1999 Jan; 29(1):12-6. PubMed ID: 10092983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Properties of beta-adrenergic receptors of heart and lung--studies with "cardioselective" beta-receptor blocking substances].
    Krawietz W; Weinsteiger M; Pruchniewski M; Erdmann E
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():414-5. PubMed ID: 26149
    [No Abstract]   [Full Text] [Related]  

  • 20. The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer.
    Montoya A; Varela-Ramirez A; Dickerson E; Pasquier E; Torabi A; Aguilera R; Nahleh Z; Bryan B
    Biomed J; 2019 Jun; 42(3):155-165. PubMed ID: 31466709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.